Codiak Biosciences Overview

Codiak Biosciences Other Income Expense Net

Other Income/Expense Net for CDAK.

Quarterly Other Income/Expense

$2.12M

↑ 1128.16% YoY

As of Sep 30, 2022

Annual Other Income/Expense (TTM)

$14.08M

↑ 1217.14% YoY

Trailing 12 months ending Sep 30, 2022

Average Other Income/Expense (Comparison Companies)

Other Income Expense Net History

Other Income Expense Net Comparison

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin